A Game-Changing Collaboration Begins

In a groundbreaking announcement made on May 7, 2025, Benchling, the cutting-edge R&D platform, has expanded its collaboration with biotech giant Moderna. Initially focused on assisting Moderna's technical development teams—including analytical tasks, technical operations, process development, and formulations—the partnership has now evolved to encompass Moderna's entire research organization. This strategic alliance will integrate hundreds of Moderna's scientists into a cohesive, AI-ready digital research platform designed to supercharge discovery and innovation.

Unlocking AI's Full Potential

Wade Davis, Senior Vice President of Digital at Moderna, highlighted the transformative role of technology in medicine: "Moderna was built on the belief that technology and science together drive breakthroughs in medicine. AI is creating extraordinary opportunities in science, but to truly harness its potential, we need entirely new methodologies. Benchling is tackling these industry-wide challenges head-on."

A New Era for Digital Transformation in Biotech

This partnership is centered around three key objectives: consolidating systems to streamline scientists' workflows, automating scientific processes, and standardizing data into consistent formats suitable for AI applications. Sajith Wickramasekara, CEO and co-founder of Benchling, emphasized the urgency of this digital shift: "R&D teams are under constant pressure to gain speed and efficiency. AI and automation can unlock unprecedented productivity—if we lay the right infrastructure."

Building the Future of AI in Biotech

Moderna's research and technical teams demanded a flexible system capable of evolving with their extensive pipeline. Benchling's digital platform meets these requirements by marrying agility with customizable scientific workflows. With the help of Benchling's developer platform, Moderna's teams are set to create bespoke workflows, automate template generation, and incorporate proprietary machine learning models. This transition significantly reduces the time needed to set up new workflows, allowing teams to zero in on innovation over system maintenance.

Seamless Integration Across Research Environments

As Benchling’s platform spreads throughout the research organization, scientists can now conduct experiments, monitor samples, and analyze results all within a single system, eliminating the clunky friction caused by disparate tools. This software also tackles a long-standing industry hurdle—integrating both structured and unstructured data from varied research settings—which lays the foundation for advanced AI-driven analytics across various therapeutic domains.

Redefining Biotech R&D

Through this innovative collaboration, Benchling and Moderna are not just keeping pace but actively redefining the future landscape of biotech research, setting a new benchmark for digital infrastructure that supports AI-driven R&D.